he SD of 0.05 with a sample variance of 0.25. The SD of the sample of occurrences [A29] of CLABSI without the CHG intervention was calculated at 0.49 with a sample variance of 0.24.Frequency of CHG Adverse Events by Month/Weeks[A30]Table 6A paired t-test was performed to calculate significance. The t- value was 0.2048

demonstrating no significance at a p- of <.05. See Table 7 for these values. This result [A31] is not significant and leads to support of the null hypothesis. The null hypothesis predicts that simulation activities will not affect patient outcomes. The lack of statistical significance noted in the project as a result of the low volume of occurrences